Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Retroperitoneal Lymph Node Dissection
100%
Mediastinal Lymph Node
100%
Diseases
46%
Lymph Node
15%
Oncology
15%
Thoracotomy
15%
Adjuvant Therapy
7%
Metastatic Carcinoma
7%
Lung Tumor
7%
Lymph Node Metastasis
7%
Right Lung
7%
Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Systematic Sampling
63%
N2 Disease
36%
Lymph Node
18%
Eastern Cooperative Oncology Group
18%
N1 Disease
18%
Metastasis
9%
Adjuvant Therapy
9%
Completely Resected
9%
Lung Tumor
9%
Median Survival
9%
Improved Survival
9%
Patient Survival
9%
Right Lung
9%
Survival Benefit
9%
Multiple Levels
9%
Complete Removal
9%
Non-randomized Comparison
9%
Left Thoracotomy
9%
Mediastinal Lymph Nodes
9%
Randomized Prospective Trial
9%
Eligibility Requirements
9%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Diseases
100%
Lung Tumor
16%
Lymph Node Metastasis
16%
Immunology and Microbiology
Lymph Node
100%
Right Lung
6%